Camp Lejeune cancer lawsuit

Politics Delayed Passing The Honoring Our Pact Act and The Camp Lejeune Justice Act Over Spending Concerns

Both the House and Senate passed the package last month before spending red flags went up

Friday, August 5, 2022 - The Honoring Our Pact Act has passed through the US House of Representatives for a second time and has met the reapproval of the Senate The Act must now be signed by the President only to become law. The main focus of The Act, as was explained to the American people in the President's State of the Union Address earlier this year, is to expand financial and medical benefits to soldiers that have been injured by toxic waste disposal burn pit contamination in the air, land, and local water supply. The bill could provide millions of military veterans treatment for Camp Lejeune cancer and other life-threatening diseases caused by inhaling toxic air hanging over their camps from burn pits. If you have been injured by drinking local tap water you should speak with a Camp Lejeune water attorney for details on filing a claim.

The passage of the bill includes the Camp Lejeune Justice Act, a piece of legislation that failed to meet Congressional approval on its own this year. The CLJA overrides a North Carolina law prohibiting individuals that were exposed to toxic PFAS forever chemicals in the local drinking water from suing the Department of Defense or the Federal government. Those opposed to the CLJA say that allowing marines, civilian Camp Lejeune employees, and their families to file lawsuits for personal injury and wrongful death could expose the Federal government and taxpayers to hundreds of billions of dollars in legal settlements. WKYC.com recently reported that the bill, one of the largest in recent history, that was once awaiting rubber-stamp approval by the President could now be in jeopardy. Medical expenses for treatment of cancer and other life-threatening illnesses from burn pit exposure in Afghanistan, Iraq, and elsewhere are currently not covered by the Veterans Administration (VA). According to WKYC, "The bill stands halted as Senator Pat Toomey (R-Pa) seeks to add an amendment regarding spending and raising concern about the allocated $300 million in benefits." The entire package had passed both the House and Senate last month before the spending red flags went up.

If you or a loved one were stationed on or near Camp Lejeune Marine installation for more than 30 days from 1953 to 1987, you should be concerned that your or your family's illness could have been prevented. The Department of Defense has admitted that they knew for decades that toxic PFAS forever chemicals were being leached into the local tap water supplies from using firefighting foam to train with and extinguish petroleum and jet-fuel fires. The Camp Lejeune Justice Act addresses US marines, their families and civilian employees, and their families that have suffered personal injuries from drinking toxic tap water. Women who drank toxic tap water during their pregnancy have had a higher than average rate of miscarriage, still-born babies, and children that have developed and died from childhood leukemia. Marines also report that they are experiencing neurological disorders like Altzheimers's and Parkinson's disease from drinking the local Camp Lejeune water.

Information provided by CampLejeuneJusticeActClaim.com, a website devoted to providing news about Camp Lejeune Justice Act Claim, including a free no-cost, no-obligation Camp Lejeune Justice Act Claim.

More Recent Camp Lejeune Water Lawsuit News:

View all Camp Lejeune Justice Act Claim News

No-Cost, No-Obligation Claim Review for Persons or Families of Persons Who Developed Cancer After Spending 30 Days or More at Camp Lejeune between 1953 and 1988

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four to date and other law firms throughout the nation often seek its experience and expertise on complex litigation.


Privacy Notice: This site uses cookies for advertising, analytics and to improve our site services. By continuing to use our site, you agree to our use of cookies. For more information, see our cookie and privacy policy.